For advanced practice providers (APPs) and nurses

Resources for your practice to help your patients

Tap into education and guidance to support you and your patients along their treatment journey

DARZALEX FASPRO® MOA video

Explains the science behind daratumumab and hyaluronidase, the active ingredients in DARZALEX FASPRO®

DARZALEX® MOA video

Explains how daratumumab, the active ingredient in DARZALEX®, works in the body

What is DARZALEX FASPRO®? patient video

Introduces patients to DARZALEX FASPRO® and helps them feel more confident about treatment

Guiding your patients through their treatment with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)

APP/patient conversation tool

Supports APP-to-patient communication about the treatment journey, including how to help patients start and stay on treatment with DARZALEX® + Rd

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) managing your multiple myeloma

Nurse conversation tool

Supports nurse-to-patient communication about multiple myeloma and treatment

Doctor conversation starter guide thumbnail

DARZALEX FASPRO® doctor conversation starter guide

Assists patients with preparing questions for their doctor about DARZALEX FASPRO®

Customized doctor conversation starter

Personalized doctor conversation starter

Allows patients to choose questions about DARZALEX FASPRO® and DARZALEX® to discuss with their doctor

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) patient brochure thumbnail

Patient brochure

Educates patients on multiple myeloma and treatment with DARZALEX FASPRO®

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) patient dosing calendar

Dosing calendar

Helps patients stay on track with their DARZALEX FASPRO® treatment regimen

Janssen Compass® 1-844-628-1234

Patient Care Navigator brochure

Provides patients with an overview of the program and how to enroll for one-on-one support

DARZALEX® + Rd treatment duration brochure thumbnail

Treatment duration brochure

Outlines the proven benefits of long-term DARZALEX® + Rd treatment and provides APPs with ongoing support to help keep patients on treatment longer

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) patient dosing calendar

Dosing calendar

Helps patients stay on track with their DARZALEX FASPRO® treatment regimen

Treatment schedule for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) + bortezomib + melphalan + prednisone regimen

Customized dosing calendar

Generates dosing calendars that patients can use for their DARZALEX FASPRO® regimen

Janssen Compass® 1-844-628-1234

Patient Care Navigator brochure

Provides patients with an overview of the program and how to enroll for one-on-one support

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) patient support from Janssen Compass®

Patient Care Navigator support

Provides one-on-one guidance, information, and education to help patients start and stay on treatment

DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) MyMilestones app

MyMilestones® app brochure

Connects patients with helpful tools, trackers, and resources to support them along their treatment journey

DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) patient and caregiver resources

Patient support organizations

Provide education, resources, and research for patients with multiple myeloma

Dosing & Administration Guide for DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) thumbnail

Dosing and administration guide

Provides step-by-step instructions on how to administer DARZALEX FASPRO® and DARZALEX®

Dosing and administration video

Demonstrates how to administer an injection of DARZALEX FASPRO®

Common questions and answers about treatment with DARZALEX FASPRO® and DARZALEX® for newly diagnosed, transplant-ineligible multiple myeloma

Explore FAQs

Get in touch

If you are a US healthcare professional, please provide your ZIP Code and contact information below if you would like us to get in touch with you.

The information you provide will be used by Janssen Biotech, Inc., our affiliates, and our service providers to contact you. Our Privacy Policy further governs the use of the information you provide.

*Required field.

[Select]
[Select]

MOA=mechanism of action; Rd=lenalidomide (R) + dexamethasone (d).